Phase II study of Gemcitabine and Curcumin (Meriva®) as first line treatment for locally advanced or metastatic pancreatic cancer: preliminary results

Line Treatment ◽

First Line ◽

Preliminary Results ◽

Capecitabine (X) plus gemcitabine (G) as first-line treatment in patients (pts) with locally advanced/metastatic pancreatic cancer: an open-label, multicenter phase II study

10.1200/jco.2005.23.16_suppl.4141 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 4141-4141 ◽

Cited By ~ 1

Author(s):

H.-S. Song ◽

Y.-R. Do ◽

H.-M. Chang ◽

K.-H. Lee ◽

Y.-H. Kim ◽

...

Keyword(s):

Pancreatic Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Line Treatment ◽

First Line ◽

Open Label ◽

Multicenter Phase ◽

P-036 Phase II study of gemcitabine and curcumin as first line treatment for locally advanced or metastatic pancreatic cancer: preliminary data

Annals of Oncology ◽

10.1093/annonc/mdv233.36 ◽

2015 ◽

Vol 26 ◽

pp. iv10

Author(s):

C. Soldà ◽

R. Bardini ◽

C. Sperti ◽

G. Da Dalt ◽

M. Gion ◽

...

Keyword(s):

Pancreatic Cancer ◽

Phase Ii ◽

Preliminary Data ◽

Phase Ii Study ◽

Locally Advanced ◽

Line Treatment ◽

First Line ◽

PACTO: A single center, randomized, phase II study of the combination of nab-paclitaxel and gemcitabine with or without tocilizumab, an IL-6R inhibitor, as first-line treatment in patients with locally advanced or metastatic pancreatic cancer

Annals of Oncology ◽

10.1093/annonc/mdx369.158 ◽

2017 ◽

Vol 28 ◽

pp. v266

Author(s):

I. Chen ◽

J.S. Johansen ◽

T.A. Zimmers ◽

C. Dehlendorff ◽

V. Kirk Parner ◽

...

Keyword(s):

Pancreatic Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Line Treatment ◽

Single Center ◽

First Line ◽

Randomized Phase Ii ◽

Multicenter randomized phase II study comparing alternate-day oral therapy using S-1 with the standard regimen as a first-line treatment for patients with locally advanced and metastatic pancreatic cancer: PAN-01 study.

10.1200/jco.2016.34.15_suppl.4107 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 4107-4107

Author(s):

Masayuki Sho ◽

Atsushi Shimizu ◽

Hiroaki Yanagimoto ◽

Shoji Nakamori ◽

Takuji Okusaka ◽

...

Keyword(s):

Pancreatic Cancer ◽

Phase Ii ◽

Oral Therapy ◽

Phase Ii Study ◽

Locally Advanced ◽

Line Treatment ◽

First Line ◽

Standard Regimen ◽

Randomized Phase Ii ◽

Gemcitabine (G) plus cisplatin (C) plus radiotherapy in first-line treatment of locally advanced and metastatic undifferentiated carcinoma of the nasopharyngeal type (UCNT): Preliminary results of a phase II study

10.1200/jco.2004.22.14_suppl.5618 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 5618-5618

Author(s):

S. Adane ◽

M. Sadouki ◽

F. Mekki ◽

K. Bouzid

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Undifferentiated Carcinoma ◽

Line Treatment ◽

First Line ◽

Preliminary Results ◽

Gemcitabine (G) plus cisplatin (C) plus radiotherapy in first-line treatment of locally advanced and metastatic undifferentiated carcinoma of the nasopharyngeal type (UCNT): Preliminary results of a phase II study

10.1200/jco.2004.22.90140.5618 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 5618-5618

Author(s):

S. Adane ◽

M. Sadouki ◽

F. Mekki ◽

K. Bouzid

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Undifferentiated Carcinoma ◽

Line Treatment ◽

First Line ◽

Preliminary Results ◽

Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-008-0873-9 ◽

2008 ◽

Vol 64 (2) ◽

pp. 317-325 ◽

Cited By ~ 11

Author(s):

Kyung Hee Lee ◽

Min Kyoung Kim ◽

Yeol Hong Kim ◽

Baek Yeol Ryoo ◽

Ho Yeong Lim ◽

...

Keyword(s):

Pancreatic Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Pancreatic Cancer ◽

Line Treatment ◽

First Line ◽

Multicenter Phase ◽

A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer

British Journal of Cancer ◽

10.1038/sj.bjc.6603301 ◽

2006 ◽

Vol 95 (5) ◽

pp. 587-592 ◽

Cited By ~ 137

Author(s):

G P Stathopoulos ◽

K Syrigos ◽

G Aravantinos ◽

A Polyzos ◽

P Papakotoulas ◽

...

Keyword(s):

Pancreatic Cancer ◽

Locally Advanced ◽

Phase Iii ◽

Line Treatment ◽

First Line ◽

Phase Iii Trial ◽

Multicenter Phase ◽

174 A phase II study of capecitabine in patients who have failed first-line treatment for locally advanced or metastatic cervix cancer (MCC)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(03)90207-2 ◽

2003 ◽

Vol 1 (5) ◽

pp. S56 ◽

Cited By ~ 1

Author(s):

V. Lorvidhaya ◽

P. Phromratanapongs ◽

I. Chitapanarux ◽

P. Kamnerdsupaphon ◽

P. Lertsanguansinchai ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Cervix Cancer ◽

Line Treatment ◽

First Line ◽

P-0014 A Phase II Study With Oxaliplatin, Leucovorin and Tegafur-Uracil as First-Line Treatment for Metastatic or Locally Advanced, Unresectable Esophageal Cancer

Annals of Oncology ◽

10.1016/s0923-7534(20)30060-0 ◽

2012 ◽

Vol 23 ◽

pp. iv34-iv35

Author(s):

Nicoline Raaschou-Jensen ◽

Kell Oesterlind ◽

Mette Yilmaz ◽

Jens Bentzen ◽

Lars Damstrup ◽

...

Keyword(s):

Esophageal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Line Treatment ◽

First Line ◽